EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹944 Cr | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr |
What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹944 Cr |
| Mar2025 | ₹852 Cr |
| Mar2024 | ₹1,097 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹768 Cr |
How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹944 Cr | 10.78 | |
| Mar2025 | ₹852 Cr | -22.38 | |
| Mar2024 | ₹1,097 Cr | 46.92 | |
| Mar2023 | ₹747 Cr | -2.78 | |
| Mar2022 | ₹768 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹42,414.1 Cr | -0.2% | 20% | 62.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.2% |
20% |
62.9% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses